Evidence map›Paper›PMID 38389491›Full record

ReviewCell proliferation2024

Ferritinophagy: A novel insight into the double-edged sword in ferritinophagy-ferroptosis axis and human diseases.

Jing-Yan Li, Yan-Hua Feng, Yu-Xuan Li, Peng-Yi He, Qi-Yuan Zhou, Ying-Ping Tian, Ren-Qi Yao, Yong-Ming Yao

Open access · goldAbstract readReview
In one paragraph

Review in Cell proliferation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
25.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators.Journal of enzyme inhibition and medicinal chemistry · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Endosomal TPC1-mediated CaProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. From lipid overload to autophagy collapse: how lipid dysregulation drives chronic inflammation and metabolic disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jing-Yan LiDepartment of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, China.ORCID https://orcid.org/0000-0003-1567-3438
Yan-Hua FengDepartment of Orthopedics, Hebei Provincial Chidren's Hospital, Shijiazhuang, China.
Yu-Xuan LiTranslational Medicine Research Center, Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital, Beijing, China.
Peng-Yi HeTranslational Medicine Research Center, Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital, Beijing, China.
Qi-Yuan ZhouDepartment of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Ying-Ping TianDepartment of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Ren-Qi YaoTranslational Medicine Research Center, Medical Innovation Research Division and Fourth Medical Center of the Chinese PLA General Hospital, Beijing, China.
Yong-Ming YaoDepartment of Emergency, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Medical University · CNChinese PLA General Hospital · CNHospital of Hebei Province · CN

Funding

National Natural Science Foundation of China 81730057National Natural Science Foundation of China 82002071National Natural Science Foundation of China 82130062National Natural Science Foundation of China 82302412Natural Science Foundation of Hebei Province H2023206202The Provincial Key Project of Medical Science Research of Hebei 20240281The Training Project of Government Funded Clinically Outstanding Personnel in Medicine 303-2022-27-12The Training Project of Government Funded Clinically Outstanding Personnel in Medicine ZF2024182
6 · The paper itself

Abstract

Nuclear receptor coactive 4 (NCOA4), which functions as a selective cargo receptor, is a critical regulator of the particularly autophagic degradation of ferritin, a process known as ferritinophagy. Mechanistically, NCOA4-mediated ferritinophagy performs an increasingly vital role in the maintenance of intracellular iron homeostasis by promoting ferritin transport and iron release as needed. Ferritinophagy is not only involved in iron-dependent responses but also in the pathogenesis and progression of various human diseases, including metabolism-related, neurodegenerative, cardiovascular and infectious diseases. Therefore, ferritinophagy is of great importance in maintaining cell viability and function and represents a potential therapeutic target. Recent studies indicated that ferritinophagy regulates the signalling pathway associated with ferroptosis, a newly discovered type of cell death characterised by iron-dependent lipid peroxidation. Although accumulating evidence clearly demonstrates the importance of the interplay between dysfunction in iron metabolism and ferroptosis, a deeper understanding of the double-edged sword effect of ferritinophagy in ferroptosis has remained elusive. Details of the mechanisms underlying the ferritinophagy-ferroptosis axis in regulating relevant human diseases remain to be elucidated. In this review, we discuss the latest research findings regarding the mechanisms that regulate the biological function of NCOA4-mediated ferritinophagy and its contribution to the pathophysiology of ferroptosis. The important role of the ferritinophagy-ferroptosis axis in human diseases will be discussed in detail, highlighting the great potential of targeting ferritinophagy in the treatment of diseases.

Indexed as

AutophagyFerritinsFerroptosisIronNuclear Receptor CoactivatorsAnimalsHumansNeurodegenerative DiseasesSignal TransductionFerritinsIronNCOA4 protein, humanNuclear Receptor Coactivators

Identifiers

PMID38389491
PMCPMC11216947
OpenAlexW4392106647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.